LOXO-195

• Description:

  LOXO-195 (Selitrectinib; LOXO 195, LOXO195) is a potent, selective, next-generation Trk tyrosine kinase inhibitor with IC50 of 0.6 nM and <2.5 nM for WT TrkA and WT TrKC, respectively.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  380.427

• Molecular Formula:

  C20H21FN6O

• Notes:

  Research use only, not for human use.

• Receptor:

  Trk Receptor

• CAS Number:

  2097002-61-2